Ticker ALT – Altimmune – sales, description, marketcap – Tickerday.com

ALT

Altimmune

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 425.22M; Volume: 391.81K; AvgVol 3m: 3.80M; Beta: 1.94;

Cost estimate:

P/E: –; EPS: -2.21; EPS growth quarter/prev quarter: -263.30%;

EPS growth this year: 89.50%; EPS growth past 5 years: 50.20%;

EPS ttm: -2.21;

P/S: 106.55; P/B: 03.07; P/Cashflow: 5.58; P/FCF: ;

Sales: 4.15M; Sales growth quarter/prev quarter: -56.30%; Sales growth past 5 years: -10.70%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -53.40%; ROE – return on equity: -66.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.01;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 6.20%; Insider Transactions:127.99%;

Institutional Ownership: 40.60%; Institutional Transactions: ;

Data update: 07.10.2020.